C-MER MEDICAL (03309) releases its interim results, with a shareholder profit of 49.944 million Hong Kong dollars, representing a year-on-year increase of 62.4%.

C-MER MEDICAL (03309) announced its performance for the six months ended June 30, 2025, with revenue of HK$944 million, a year-on-year increase of 2.4%; the profit attributable to equity holders of the company was HK$49.944 million, a year-on-year increase of 62.4%; basic earnings per share were HK$0.411. The slight increase in revenue during the period was due to the increasing demand for ophthalmic medical services in the Hong Kong market, leading to growth in revenue from ophthalmic services in Hong Kong. However, this was partially offset by a decrease in revenue from dental services and ophthalmic services in Shenzhen due to intense competition.